CD274 and neoplasm: Potential interactions between Tpex cells and mregDCs in tumours were identified, indicating that minP1 served as an immunoadjuvant that promoted the effectiveness of anti‐PD‐L1 immunotherapy, resulting in increased Tpex cells in tumours.47